Low [mu]-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis

Blockade of the μ-opioid receptor (MOR) by naltrexone reduces relapse risk in a subpopulation of alcohol-dependent patients. Previous positron-emission-tomography (PET) studies using the MOR ligand [11C]carfentanil have found increased MOR availability in abstinent alcoholics, which may reflect eith...

Full description

Saved in:
Bibliographic Details
Main Authors: Hermann, Derik (Author) , Smolka, Michael (Author) , Kiefer, Falk (Author) , Noori, Hamid Reza (Author) , Sommer, Wolfgang H. (Author) , Mann, Karl (Author) , Spanagel, Rainer (Author)
Format: Article (Journal)
Language:English
Published: 21 September 2016
In: Neuropsychopharmacology
Year: 2016, Volume: 42, Issue: 3, Pages: 606-614
ISSN:1740-634X
DOI:10.1038/npp.2016.145
Online Access:Verlag, teilw. kostenfrei, Volltext: http://dx.doi.org/10.1038/npp.2016.145
Verlag, teilw. kostenfrei, Volltext: https://www-nature-com.ezproxy.medma.uni-heidelberg.de/articles/npp2016145
Get full text
Author Notes:Derik Hermann, Natalie Hirth, Matthias Reimold, Anil Batra, Michael N. Smolka, Sabine Hoffmann, Falk Kiefer, Hamid R. Noori, Wolfgang H. Sommer, Gerald Reischl, Christian la Fougère, Karl Mann, Rainer Spanagel and Anita C. Hansson

MARC

LEADER 00000caa a2200000 c 4500
001 1572590920
003 DE-627
005 20230426124312.0
007 cr uuu---uuuuu
008 180503r20172016xx |||||o 00| ||eng c
024 7 |a 10.1038/npp.2016.145  |2 doi 
035 |a (DE-627)1572590920 
035 |a (DE-576)502590920 
035 |a (DE-599)BSZ502590920 
035 |a (OCoLC)1341008268 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hermann, Derik  |d 1972-  |e VerfasserIn  |0 (DE-588)121855139  |0 (DE-627)705679047  |0 (DE-576)292920490  |4 aut 
245 1 0 |a Low [mu]-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis  |c Derik Hermann, Natalie Hirth, Matthias Reimold, Anil Batra, Michael N. Smolka, Sabine Hoffmann, Falk Kiefer, Hamid R. Noori, Wolfgang H. Sommer, Gerald Reischl, Christian la Fougère, Karl Mann, Rainer Spanagel and Anita C. Hansson 
246 3 0 |a Low mu-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis 
246 3 3 |a Low μ-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis 
264 1 |c 21 September 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.05.2018 
520 |a Blockade of the μ-opioid receptor (MOR) by naltrexone reduces relapse risk in a subpopulation of alcohol-dependent patients. Previous positron-emission-tomography (PET) studies using the MOR ligand [11C]carfentanil have found increased MOR availability in abstinent alcoholics, which may reflect either increased MOR expression or lower endogenous ligand concentration. To differentiate between both effects, we investigated two cohorts of alcoholic subjects using either post-mortem or clinical PET analysis. Post-mortem brain tissue of alcohol-dependent subjects and controls (N=43/group) was quantitatively analyzed for MOR ([3H]DAMGO)-binding sites and OPRM1 mRNA in striatal regions. [11C]carfentanil PET was performed in detoxified, medication free alcohol-dependent patients (N=38), followed by a randomized controlled study of naltrexone versus placebo and follow-up for 1 year (clinical trial number: NCT00317031). Because the functional OPRM1 variant rs1799971:A>G affects the ligand binding, allele carrier status was considered in the analyses. MOR-binding sites were reduced by 23-51% in post-mortem striatal tissue of alcoholics. In the PET study, a significant interaction of OPRM1 genotype, binding potential (BPND) for [11C]carfentanil in the ventral striatum, and relapse risk was found. Particularly in G-allele carriers, lower striatal BPND was associated with a higher relapse risk. Interestingly, this effect was more pronounced in the naltrexone treatment group. Reduced MOR is interpreted as a neuroadaptation to an alcohol-induced release of endogenous ligands in patients with severe alcoholism. Low MOR availability may explain the ineffectiveness of naltrexone treatment in this subpopulation. Finally, low MOR-binding sites are proposed as a molecular marker for a negative disease course. 
534 |c 2016 
700 1 |a Smolka, Michael  |e VerfasserIn  |0 (DE-588)1073229319  |0 (DE-627)828684685  |0 (DE-576)43475286X  |4 aut 
700 1 |a Kiefer, Falk  |d 1969-  |e VerfasserIn  |0 (DE-588)140919635  |0 (DE-627)703829033  |0 (DE-576)176310339  |4 aut 
700 1 |a Noori, Hamid Reza  |d 1982-  |e VerfasserIn  |0 (DE-588)136385877  |0 (DE-627)58206872X  |0 (DE-576)300993609  |4 aut 
700 1 |a Sommer, Wolfgang H.  |e VerfasserIn  |0 (DE-588)1025859626  |0 (DE-627)725315350  |0 (DE-576)370844076  |4 aut 
700 1 |a Mann, Karl  |d 1948-  |e VerfasserIn  |0 (DE-588)120426455  |0 (DE-627)080667872  |0 (DE-576)187088012  |4 aut 
700 1 |a Spanagel, Rainer  |d 1961-  |e VerfasserIn  |0 (DE-588)112706312  |0 (DE-627)521941261  |0 (DE-576)289740002  |4 aut 
773 0 8 |i Enthalten in  |t Neuropsychopharmacology  |d London : Springer Nature, 1993  |g 42(2017), 3, Seite 606-614  |h Online-Ressource  |w (DE-627)320469190  |w (DE-600)2008300-2  |w (DE-576)096188707  |x 1740-634X  |7 nnas  |a Low [mu]-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis 
773 1 8 |g volume:42  |g year:2017  |g number:3  |g pages:606-614  |g extent:9  |a Low [mu]-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis 
856 4 0 |u http://dx.doi.org/10.1038/npp.2016.145  |x Verlag  |x Resolving-System  |z teilw. kostenfrei  |3 Volltext 
856 4 0 |u https://www-nature-com.ezproxy.medma.uni-heidelberg.de/articles/npp2016145  |x Verlag  |z teilw. kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180503 
993 |a Article 
994 |a 2017 
998 |g 112706312  |a Spanagel, Rainer  |m 112706312:Spanagel, Rainer  |d 60000  |e 60000PS112706312  |k 0/60000/  |p 13 
998 |g 120426455  |a Mann, Karl  |m 120426455:Mann, Karl  |d 60000  |e 60000PM120426455  |k 0/60000/  |p 12 
998 |g 1025859626  |a Sommer, Wolfgang H.  |m 1025859626:Sommer, Wolfgang H.  |d 60000  |e 60000PS1025859626  |k 0/60000/  |p 9 
998 |g 136385877  |a Noori, Hamid Reza  |m 136385877:Noori, Hamid Reza  |d 60000  |e 60000PN136385877  |k 0/60000/  |p 8 
998 |g 140919635  |a Kiefer, Falk  |m 140919635:Kiefer, Falk  |d 60000  |e 60000PK140919635  |k 0/60000/  |p 7 
998 |g 1073229319  |a Smolka, Michael  |m 1073229319:Smolka, Michael  |d 60000  |e 60000PS1073229319  |k 0/60000/  |p 5 
998 |g 121855139  |a Hermann, Derik  |m 121855139:Hermann, Derik  |d 60000  |e 60000PH121855139  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1572590920  |e 3007842972 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"titleAlt":[{"title":"Low μ-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis"}],"origin":[{"dateIssuedDisp":"21 September 2016","dateIssuedKey":"2017"}],"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.1038/npp.2016.145"],"eki":["1572590920"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["Nachgewiesen 8.1993 -"],"part":{"year":"2017","issue":"3","text":"42(2017), 3, Seite 606-614","extent":"9","pages":"606-614","volume":"42"},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"London ; Amsterdam [u.a.] ; London","dateIssuedDisp":"1993-","dateIssuedKey":"1993","publisher":"Springer Nature ; Elsevier Science ; Nature Publ. Group"}],"note":["Ungezählte Beil.: Supplement"],"id":{"issn":["1740-634X"],"eki":["320469190"],"zdb":["2008300-2"]},"recId":"320469190","disp":"Low [mu]-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysisNeuropsychopharmacology","language":["eng"],"title":[{"title":"Neuropsychopharmacology","subtitle":"official publication of the American College of Neuropsychopharmacology","title_sort":"Neuropsychopharmacology"}]}],"recId":"1572590920","person":[{"given":"Derik","roleDisplay":"VerfasserIn","role":"aut","family":"Hermann","display":"Hermann, Derik"},{"display":"Smolka, Michael","family":"Smolka","role":"aut","roleDisplay":"VerfasserIn","given":"Michael"},{"display":"Kiefer, Falk","family":"Kiefer","role":"aut","roleDisplay":"VerfasserIn","given":"Falk"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Noori","display":"Noori, Hamid Reza","given":"Hamid Reza"},{"given":"Wolfgang H.","family":"Sommer","display":"Sommer, Wolfgang H.","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Mann, Karl","family":"Mann","given":"Karl"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Spanagel, Rainer","family":"Spanagel","given":"Rainer"}],"note":["Gesehen am 03.05.2018"],"language":["eng"],"name":{"displayForm":["Derik Hermann, Natalie Hirth, Matthias Reimold, Anil Batra, Michael N. Smolka, Sabine Hoffmann, Falk Kiefer, Hamid R. Noori, Wolfgang H. Sommer, Gerald Reischl, Christian la Fougère, Karl Mann, Rainer Spanagel and Anita C. Hansson"]},"title":[{"title_sort":"Low [mu]-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis","title":"Low [mu]-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis"}]} 
SRT |a HERMANNDERLOWMUOPIOI2120